Use of electronic data to raise the standard of cancer care

Drugging the cancer genome: opportunities and challenges

A new direction for development of targeted cancer therapies

Vandetanib increases progression free survival in medullary thyroid carcinoma

WINTHER: The WIN therapeutics clinical trial

Emerging advances in multiple myeloma; expert roundtable at MM CTP 2012

Use of genetic variance to identify potential therapeutic targets

Application of next generation sequencing

Importance of early detection and the ‘Beyond the Shock’ programme

Mouse models and proteomics tackling acute lymphoblastic leukaemia

Assessing iron overload and toxicity

Impressive results with a bispecific antibody for ALL